Thurston Group Closes Oversubscribed Fund III at $211 Million Hard Cap
Fund III marks Thurston's third successful fundraise since 2018 and reinforces the firm's position as a preeminent investor in the lower middle-market healthcare sector. Leveraging its proven playbook to drive growth and long-term value creation, the Fund will continue Thurston's strategy of making control investments in attractive segments of healthcare, partnering with founder-owners of businesses.
"We are deeply grateful for the support from existing investors for this fundraise, as well as the new strategic partnerships we have created in Fund III, which further diversifies our investor base among high-quality family offices, fund-of-funds, and high-net-worth individuals," said
Founded in 1986, Thurston partners with entrepreneurial healthcare professionals to build long-lasting legacy businesses through a collaborative, value-added approach. Since inception, the firm has returned more than
"Fund III represents the next chapter in our evolution as a firm," added Patrick J. Haynes III, Chairman and Founder of Thurston Group. "Our team is deeply focused on building enduring partnerships with high-performing healthcare operators, and we are excited to deploy this capital into businesses where we can bring meaningful operational and strategic support."
Nixon Peabody LLP served as fund counsel, and Praxess Securities, LLC served as placement agent to Thurston.
For media inquiries, please contact:
Vice President
Thurston Group
(312) 255-0077
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/thurston-group-closes-oversubscribed-fund-iii-at-211-million-hard-cap-302506235.html
SOURCE Thurston Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Actions will help translate vision for Sino-US ties into reality: China Daily editorial
- MagLev Aero Secures Dual DARPA Contracts to Advance Next-Generation U.S. Drone Propulsion
- MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share